JP3207000005
JP3207000005
KAKEN PHARMACEUTICAL
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 76.871.000.000 | 94.035.000.000 | 18.3% |
| Cost of Revenue | 36.879.000.000 | 35.502.000.000 | 3.9% |
| Gross Profit | 39.991.000.000 | 58.532.000.000 | 31.7% |
| 40.888.000.000 | 37.494.000.000 | 9.1% | |
| Operating Income | -897.000.000 | 21.038.000.000 | 104.3% |
| Pretax Income | 2.313.000.000 | 19.435.000.000 | 88.1% |
| Net Income Common Stockholders | 2.144.000.000 | 13.945.000.000 | 84.6% |
| -- | -- | -- | |
| -- | -- | -- |